HEADER APOPTOSIS 07-SEP-99 1CZY TITLE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE TRAF DOMAIN OF HUMAN TITLE 2 TRAF2 AND AN LMP1 BINDING PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: TRAF DOMAIN; COMPND 5 SYNONYM: TRAF2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: LATENT MEMBRANE PROTEIN 1; COMPND 9 CHAIN: D, E; COMPND 10 FRAGMENT: TRAF2-BINDING REGION; COMPND 11 SYNONYM: LMP1; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET24D; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 12 OF THIS PEPTIDE NATURALLY OCCURS IN HUMANS (HOMO SAPIENS) KEYWDS BETA SANDWICH, PROTEIN-PEPTIDE COMPLEX, SIGNALING PROTEIN, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR H.YE,Y.C.PARK,M.KREISHMAN,E.KIEFF,H.WU REVDAT 5 31-JAN-18 1CZY 1 REMARK REVDAT 4 04-OCT-17 1CZY 1 REMARK REVDAT 3 24-FEB-09 1CZY 1 VERSN REVDAT 2 01-APR-03 1CZY 1 JRNL REVDAT 1 08-MAR-00 1CZY 0 JRNL AUTH H.YE,Y.C.PARK,M.KREISHMAN,E.KIEFF,H.WU JRNL TITL THE STRUCTURAL BASIS FOR THE RECOGNITION OF DIVERSE RECEPTOR JRNL TITL 2 SEQUENCES BY TRAF2. JRNL REF MOL.CELL V. 4 321 1999 JRNL REFN ISSN 1097-2765 JRNL PMID 10518213 JRNL DOI 10.1016/S1097-2765(00)80334-2 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.C.PARK,V.BURKITT,A.R.VILLA,L.TONG,H.WU REMARK 1 TITL STRUCTURAL BASIS FOR SELF-ASSOCIATION AND RECEPTOR REMARK 1 TITL 2 RECOGNITION OF HUMAN TRAF2 REMARK 1 REF NATURE V. 398 533 1999 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/19110 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : 6% REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3957 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 391 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CZY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-SEP-99. REMARK 100 THE DEPOSITION ID IS D_1000009661. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.018 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SOFTWARE AT SYNCHROTRON REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: REPLACE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4K, MES BUFFER, PH 6.00, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 20K, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.40000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE DEPOSITED TRAF2-RECEPTOR PEPTIDE COMPLEX REMARK 400 CONTAINS 3 TRAF2 PER ASYMMETRIC UNIT, REMARK 400 ONE OF WHICH DOES NOT HAVE THE PEPTIDE BOUND REMARK 400 DUE TO CONFLICT WITH CRYSTAL PACKING. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ACE E 203 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 335 CG SD CE REMARK 470 ASP A 337 CG OD1 OD2 REMARK 470 GLU A 339 CG CD OE1 OE2 REMARK 470 GLN A 340 CG CD OE1 NE2 REMARK 470 LYS A 341 CG CD CE NZ REMARK 470 GLU A 344 CG CD OE1 OE2 REMARK 470 PRO A 362 CG CD REMARK 470 ARG A 403 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 423 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 440 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 441 CG CD OE1 OE2 REMARK 470 GLU A 479 CG CD OE1 OE2 REMARK 470 LYS A 481 CG CD CE NZ REMARK 470 MET B 335 CG SD CE REMARK 470 ASP B 337 CG OD1 OD2 REMARK 470 GLU B 339 CG CD OE1 OE2 REMARK 470 GLN B 340 CG CD OE1 NE2 REMARK 470 LYS B 341 CG CD CE NZ REMARK 470 GLU B 344 CG CD OE1 OE2 REMARK 470 PRO B 362 CG CD REMARK 470 ARG B 403 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 423 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 440 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 441 CG CD OE1 OE2 REMARK 470 GLU B 479 CG CD OE1 OE2 REMARK 470 LYS B 481 CG CD CE NZ REMARK 470 MET C 335 CG SD CE REMARK 470 ASP C 337 CG OD1 OD2 REMARK 470 GLU C 339 CG CD OE1 OE2 REMARK 470 GLN C 340 CG CD OE1 NE2 REMARK 470 LYS C 341 CG CD CE NZ REMARK 470 GLU C 344 CG CD OE1 OE2 REMARK 470 PRO C 362 CG CD REMARK 470 ARG C 403 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 423 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 440 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 441 CG CD OE1 OE2 REMARK 470 GLU C 479 CG CD OE1 OE2 REMARK 470 LYS C 481 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP E 210 O HOH E 6233 1.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 335 -16.11 -44.36 REMARK 500 ASN A 427 43.98 -140.29 REMARK 500 ARG A 440 -89.91 -91.67 REMARK 500 VAL A 451 -19.04 -47.52 REMARK 500 MET A 478 -123.32 -90.90 REMARK 500 GLU A 479 -69.02 7.71 REMARK 500 ALA A 480 -81.73 -30.31 REMARK 500 LYS A 481 -118.77 -145.82 REMARK 500 ASN A 482 -168.41 58.97 REMARK 500 ASN B 427 43.22 -140.52 REMARK 500 LEU B 471 51.15 -117.77 REMARK 500 MET B 478 -122.53 -78.70 REMARK 500 GLU B 479 -75.51 7.93 REMARK 500 ALA B 480 -84.32 -21.65 REMARK 500 LYS B 481 -109.54 -145.92 REMARK 500 ASN B 482 -165.17 55.97 REMARK 500 ASN C 427 42.85 -140.95 REMARK 500 LEU C 471 44.66 -109.56 REMARK 500 MET C 478 -130.24 -73.26 REMARK 500 GLU C 479 -81.44 13.71 REMARK 500 ALA C 480 -90.21 -18.06 REMARK 500 LYS C 481 -121.55 -138.72 REMARK 500 ASN C 482 -167.00 63.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE D 203 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CA4 RELATED DB: PDB REMARK 900 1CA4 CONTAINS THE SAME PROTEIN IN UNCOMPLEXED FORM REMARK 900 RELATED ID: 1CA9 RELATED DB: PDB REMARK 900 1CA9 CONTAINS A LONGER CONSTRUCT OF THE SAME PROTEIN IN COMPLEX REMARK 900 WITH TNF-R2 PEPTIDE REMARK 900 RELATED ID: 1CZZ RELATED DB: PDB REMARK 900 RELATED ID: 1D00 RELATED DB: PDB REMARK 900 RELATED ID: 1D01 RELATED DB: PDB REMARK 900 RELATED ID: 1D0J RELATED DB: PDB REMARK 900 RELATED ID: 1D0A RELATED DB: PDB DBREF 1CZY A 334 501 UNP Q12933 TRAF2_HUMAN 334 501 DBREF 1CZY B 334 501 UNP Q12933 TRAF2_HUMAN 334 501 DBREF 1CZY C 334 501 UNP Q12933 TRAF2_HUMAN 334 501 DBREF 1CZY D 204 210 UNP P03230 LMP1_EBV 204 210 DBREF 1CZY E 204 210 UNP P03230 LMP1_EBV 204 210 SEQADV 1CZY ARG A 365 UNP Q12933 LEU 365 CONFLICT SEQADV 1CZY ARG B 365 UNP Q12933 LEU 365 CONFLICT SEQADV 1CZY ARG C 365 UNP Q12933 LEU 365 CONFLICT SEQRES 1 A 168 ALA MET ALA ASP LEU GLU GLN LYS VAL LEU GLU MET GLU SEQRES 2 A 168 ALA SER THR TYR ASP GLY VAL PHE ILE TRP LYS ILE SER SEQRES 3 A 168 ASP PHE PRO ARG LYS ARG GLN GLU ALA VAL ALA GLY ARG SEQRES 4 A 168 ILE PRO ALA ILE PHE SER PRO ALA PHE TYR THR SER ARG SEQRES 5 A 168 TYR GLY TYR LYS MET CYS LEU ARG ILE TYR LEU ASN GLY SEQRES 6 A 168 ASP GLY THR GLY ARG GLY THR HIS LEU SER LEU PHE PHE SEQRES 7 A 168 VAL VAL MET LYS GLY PRO ASN ASP ALA LEU LEU ARG TRP SEQRES 8 A 168 PRO PHE ASN GLN LYS VAL THR LEU MET LEU LEU ASP GLN SEQRES 9 A 168 ASN ASN ARG GLU HIS VAL ILE ASP ALA PHE ARG PRO ASP SEQRES 10 A 168 VAL THR SER SER SER PHE GLN ARG PRO VAL ASN ASP MET SEQRES 11 A 168 ASN ILE ALA SER GLY CYS PRO LEU PHE CYS PRO VAL SER SEQRES 12 A 168 LYS MET GLU ALA LYS ASN SER TYR VAL ARG ASP ASP ALA SEQRES 13 A 168 ILE PHE ILE LYS ALA ILE VAL ASP LEU THR GLY LEU SEQRES 1 B 168 ALA MET ALA ASP LEU GLU GLN LYS VAL LEU GLU MET GLU SEQRES 2 B 168 ALA SER THR TYR ASP GLY VAL PHE ILE TRP LYS ILE SER SEQRES 3 B 168 ASP PHE PRO ARG LYS ARG GLN GLU ALA VAL ALA GLY ARG SEQRES 4 B 168 ILE PRO ALA ILE PHE SER PRO ALA PHE TYR THR SER ARG SEQRES 5 B 168 TYR GLY TYR LYS MET CYS LEU ARG ILE TYR LEU ASN GLY SEQRES 6 B 168 ASP GLY THR GLY ARG GLY THR HIS LEU SER LEU PHE PHE SEQRES 7 B 168 VAL VAL MET LYS GLY PRO ASN ASP ALA LEU LEU ARG TRP SEQRES 8 B 168 PRO PHE ASN GLN LYS VAL THR LEU MET LEU LEU ASP GLN SEQRES 9 B 168 ASN ASN ARG GLU HIS VAL ILE ASP ALA PHE ARG PRO ASP SEQRES 10 B 168 VAL THR SER SER SER PHE GLN ARG PRO VAL ASN ASP MET SEQRES 11 B 168 ASN ILE ALA SER GLY CYS PRO LEU PHE CYS PRO VAL SER SEQRES 12 B 168 LYS MET GLU ALA LYS ASN SER TYR VAL ARG ASP ASP ALA SEQRES 13 B 168 ILE PHE ILE LYS ALA ILE VAL ASP LEU THR GLY LEU SEQRES 1 C 168 ALA MET ALA ASP LEU GLU GLN LYS VAL LEU GLU MET GLU SEQRES 2 C 168 ALA SER THR TYR ASP GLY VAL PHE ILE TRP LYS ILE SER SEQRES 3 C 168 ASP PHE PRO ARG LYS ARG GLN GLU ALA VAL ALA GLY ARG SEQRES 4 C 168 ILE PRO ALA ILE PHE SER PRO ALA PHE TYR THR SER ARG SEQRES 5 C 168 TYR GLY TYR LYS MET CYS LEU ARG ILE TYR LEU ASN GLY SEQRES 6 C 168 ASP GLY THR GLY ARG GLY THR HIS LEU SER LEU PHE PHE SEQRES 7 C 168 VAL VAL MET LYS GLY PRO ASN ASP ALA LEU LEU ARG TRP SEQRES 8 C 168 PRO PHE ASN GLN LYS VAL THR LEU MET LEU LEU ASP GLN SEQRES 9 C 168 ASN ASN ARG GLU HIS VAL ILE ASP ALA PHE ARG PRO ASP SEQRES 10 C 168 VAL THR SER SER SER PHE GLN ARG PRO VAL ASN ASP MET SEQRES 11 C 168 ASN ILE ALA SER GLY CYS PRO LEU PHE CYS PRO VAL SER SEQRES 12 C 168 LYS MET GLU ALA LYS ASN SER TYR VAL ARG ASP ASP ALA SEQRES 13 C 168 ILE PHE ILE LYS ALA ILE VAL ASP LEU THR GLY LEU SEQRES 1 D 8 ACE PRO GLN GLN ALA THR ASP ASP SEQRES 1 E 8 ACE PRO GLN GLN ALA THR ASP ASP HET ACE D 203 3 HETNAM ACE ACETYL GROUP FORMUL 4 ACE C2 H4 O FORMUL 6 HOH *391(H2 O) HELIX 1 1 ALA A 334 SER A 348 1 15 HELIX 2 2 ASP A 360 ALA A 370 1 11 HELIX 3 4 ASN A 418 LEU A 422 5 5 HELIX 4 5 SER A 453 GLN A 457 5 5 HELIX 5 6 ALA B 334 SER B 348 1 15 HELIX 6 7 ASP B 360 ALA B 370 1 11 HELIX 7 9 ASN B 418 LEU B 422 5 5 HELIX 8 10 SER B 453 GLN B 457 5 5 HELIX 9 11 ALA C 334 SER C 348 1 15 HELIX 10 12 ASP C 360 ALA C 370 1 11 HELIX 11 14 ASN C 418 LEU C 422 5 5 HELIX 12 15 SER C 453 GLN C 457 5 5 SHEET 1 A 4 VAL A 353 ILE A 358 0 SHEET 2 A 4 ILE A 490 VAL A 496 -1 O ILE A 490 N ILE A 358 SHEET 3 A 4 VAL A 430 LEU A 434 -1 N THR A 431 O ILE A 495 SHEET 4 A 4 VAL A 443 PHE A 447 -1 N VAL A 443 O LEU A 434 SHEET 1 B 5 GLN D 205 GLN D 206 0 SHEET 2 B 5 SER A 467 PRO A 474 -1 N GLY A 468 O GLN D 205 SHEET 3 B 5 HIS A 406 MET A 414 -1 N LEU A 407 O CYS A 473 SHEET 4 B 5 LYS A 389 TYR A 395 -1 O LYS A 389 N MET A 414 SHEET 5 B 5 ILE A 376 PHE A 377 -1 O ILE A 376 N ILE A 394 SHEET 1 C 5 GLN D 205 GLN D 206 0 SHEET 2 C 5 SER A 467 PRO A 474 -1 N GLY A 468 O GLN D 205 SHEET 3 C 5 HIS A 406 MET A 414 -1 N LEU A 407 O CYS A 473 SHEET 4 C 5 LYS A 389 TYR A 395 -1 O LYS A 389 N MET A 414 SHEET 5 C 5 PHE A 381 TYR A 382 -1 O PHE A 381 N MET A 390 SHEET 1 D 4 VAL B 353 SER B 359 0 SHEET 2 D 4 ALA B 489 VAL B 496 -1 O ILE B 490 N ILE B 358 SHEET 3 D 4 VAL B 430 LEU B 434 -1 N THR B 431 O ILE B 495 SHEET 4 D 4 VAL B 443 PHE B 447 -1 N VAL B 443 O LEU B 434 SHEET 1 E 4 SER B 467 PRO B 474 0 SHEET 2 E 4 HIS B 406 MET B 414 -1 N LEU B 407 O CYS B 473 SHEET 3 E 4 LYS B 389 TYR B 395 -1 O LYS B 389 N MET B 414 SHEET 4 E 4 ILE B 376 PHE B 377 -1 O ILE B 376 N ILE B 394 SHEET 1 F 4 SER B 467 PRO B 474 0 SHEET 2 F 4 HIS B 406 MET B 414 -1 N LEU B 407 O CYS B 473 SHEET 3 F 4 LYS B 389 TYR B 395 -1 O LYS B 389 N MET B 414 SHEET 4 F 4 PHE B 381 TYR B 382 -1 O PHE B 381 N MET B 390 SHEET 1 G 4 VAL C 353 ILE C 358 0 SHEET 2 G 4 ILE C 490 VAL C 496 -1 O ILE C 490 N ILE C 358 SHEET 3 G 4 VAL C 430 LEU C 434 -1 N THR C 431 O ILE C 495 SHEET 4 G 4 VAL C 443 PHE C 447 -1 N VAL C 443 O LEU C 434 SHEET 1 H 5 GLN E 205 GLN E 206 0 SHEET 2 H 5 SER C 467 PRO C 474 -1 N GLY C 468 O GLN E 205 SHEET 3 H 5 HIS C 406 MET C 414 -1 N LEU C 407 O CYS C 473 SHEET 4 H 5 LYS C 389 TYR C 395 -1 O LYS C 389 N MET C 414 SHEET 5 H 5 ILE C 376 PHE C 377 -1 O ILE C 376 N ILE C 394 SHEET 1 I 5 GLN E 205 GLN E 206 0 SHEET 2 I 5 SER C 467 PRO C 474 -1 N GLY C 468 O GLN E 205 SHEET 3 I 5 HIS C 406 MET C 414 -1 N LEU C 407 O CYS C 473 SHEET 4 I 5 LYS C 389 TYR C 395 -1 O LYS C 389 N MET C 414 SHEET 5 I 5 PHE C 381 TYR C 382 -1 O PHE C 381 N MET C 390 LINK C ACE D 203 N PRO D 204 1555 1555 1.34 CISPEP 1 TRP A 424 PRO A 425 0 -0.23 CISPEP 2 TRP B 424 PRO B 425 0 -0.04 CISPEP 3 TRP C 424 PRO C 425 0 -0.02 SITE 1 AC1 1 HOH D6225 CRYST1 56.200 76.800 66.900 90.00 93.20 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017794 0.000000 0.000995 0.00000 SCALE2 0.000000 0.013021 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014971 0.00000